Cancer is among the leading causes of death worldwide. Approximately 40% of men and women will be diagnosed with cancer at some point in their lifetimes. While cancer treatment advances have caused cancer mortality rate to drop by 25% since the early 90s, treatment prices have skyrocketed; with drug treatment ranging from $100,000 to $400,000 per year for many new cancer drugs. How do health care purchasers, such as employers and union trusts, know if their members are getting the right care?

Over the last few months, the Alliance has hosted several opportunities to learn more about cancer treatment and is adding additional sessions in December. Purchasers and health care partners such as brokers and consultants can find out how they can work with health plans, providers, and PBMs to identify care that is inconsistent with best practice guidelines, such as the frequency of colonoscopies and screenings, and ways to eliminate low-value care. This program focuses on how cancer care is evolving to deliver patient-centered care and will cover the patient journey from prevention, diagnosis, and treatment, through remission and surveillance, and back to work strategies.

Space is limited. If you are interested in participating, please contact Director of Membership and Business Engagement Theresa Lampkin Tamura. This opportunity is made possible by support from the National Alliance of Healthcare Purchaser Coalitions.